A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
NCT ID: NCT06616194
Last Updated: 2026-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
200 participants
INTERVENTIONAL
2024-11-15
2027-12-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Rimegepant is a tablet that dissolves when you put it on or under your tongue.
The study will enroll participants who have headache for 15 days (or more) every month, of which 8 days (or more) of migraine every month, and each untreated attack lasts for an average of 4-72 hours
In the 1st part of the study approximately half of the participants will receive a rimegepant tablet every other day, and approximately half of the participants will receive an inactive oral tablet (that looks the same as the rimegepant tablet) every other day.
Participant experiences when they are taking the study medicine will be compared to when they are taking the inactive tablet. This will help to determine if the study medicine is safe and effective. The 1st phase of the study will last 3 months.
In the 2nd part of the study all the participants who stay on study will receive rimegepant tablet every other day. This 2nd phase of the study will last 1 year. This will help determine if the study medicine is safe when taken for a long period.
Those who will participate in both phases will have up to 19 visits at the study clinic, about one every 4 weeks (this may vary from 2 to 8 weeks interval during the study). Home health visits may occur as well. A health check and blood sample will be conducted at all visits. Participants will have to complete a daily diary to record the migraine attacks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
NCT06641466
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
NCT05156398
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
NCT04743141
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
NCT04649242
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
NCT05518123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rimegepant
Experimental medicine under study
Rimegepant
Rimegepant 75 mg orally disintegrating tablets
Placebo
A placebo does not have any medicine in it but looks just like the medicine being studied.
Placebo
Matching placebo oral disintegrating tablets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rimegepant
Rimegepant 75 mg orally disintegrating tablets
Placebo
Matching placebo oral disintegrating tablets
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 15 or more headache days/month
* 8 or more migraine days/month
* Migraine lasting 4-72 hours if untreated
Exclusion Criteria
* Current psychiatric condition uncontrolled or untreated
* History of suicidal behavior or the subject is at risk of self-harm
* History of alcohol abuse and/or illicit drug use
* History of severe drug allergy
* Use of more than one medication for migraine prevention/prophylaxis
* Participation in another clinical trial at the same time
12 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Adult & Child Neurology Medical Associates
Long Beach, California, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Chicago Headache Center and Research Institute
Chicago, Illinois, United States
Chicago Headache Center and Research Institute
Naperville, Illinois, United States
New England Regional Headache Center
Worcester, Massachusetts, United States
Michigan Headache & Neurological Institute
Ann Arbor, Michigan, United States
Clinvest Headlands Llc
Springfield, Missouri, United States
Rutgers University
New Brunswick, New Jersey, United States
OnSite Clinical Solutions, LLC
Charlotte, North Carolina, United States
OnSite Clinical Solutions
Charlotte, North Carolina, United States
Duke Health Center Creekstone
Durham, North Carolina, United States
Duke Lenox Baker Children's
Durham, North Carolina, United States
Duke Children's Health Center
Durham, North Carolina, United States
Wake Forest University Baptist Medical Center ( WFUBMC )
Winston-Salem, North Carolina, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Avera Medical Group Pediatric Specialists
Sioux Falls, South Dakota, United States
Avera Research Institute - Sioux Falls
Sioux Falls, South Dakota, United States
Avera Medical Group Pediatrics - Dawley Farm
Sioux Falls, South Dakota, United States
Dell Children's Medical Center
Austin, Texas, United States
Headlands Research-El Paso
El Paso, Texas, United States
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Wasatch Clinical Research, LLC
Salt Lake City, Utah, United States
Granger Medical Holladay - Holladay Clinic
Salt Lake City, Utah, United States
Seattle Children's Hospital
Seattle, Washington, United States
University Of Alberta Hospital
Edmonton, Alberta, Canada
Stollery Children's Hospital
Edmonton, Alberta, Canada
CaRe Clinic
Red Deer, Alberta, Canada
London Health Sciences Centre - Verspeeten Family Cancer Centre
London, Ontario, Canada
Anhui Provincial Hospital
Hefei, Anhui, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Guangzhou First People's Hospital
Guangzhou, Guangdong, China
Jingzhou First People's Hospital
Jingzhou, Hubei, China
Wuhan Children's Hospital
Wuhan, Hubei, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Wuxi Children's Hospital
Wuxi, Jiangsu, China
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, China
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
Shanghai Children's Hospital
Shanghai, , China
The Second Affiliated Hospital of Hebei Medical University
Shijiazhuang, , China
Detska nemocnice FN Brno
Brno, Brno-město, Czechia
Fakultni nemocnice Hradec Kralove
Hradec Králové, Hradec Králové, Czechia
Fakultni nemocnice Ostrava
Ostrava, Moravskoslezský kraj, Czechia
Fakultni Thomayerova nemocnice
Prague, Praha 4, Czechia
Fakultni nemocnice v Motole
Prague, Praha 5, Czechia
Terveystalo Oulu
Oulu, North Ostrobothnia, Finland
Kuopion Yliopistollinen Sairaala
Kuopio, Northern Savonia, Finland
Tampereen yliopistollinen sairaala
Tampere, Pirkanmaa, Finland
Turku University Hospital
Turku, Southwest Finland, Finland
New Children's Hospital
Helsinki, Uusimaa, Finland
Terveystalo Tampere
Tampere, , Finland
Terveystalo Pulssi
Turku, , Finland
Dr. Kenessey Albert Kórház
Balassagyarmat, Nógrád megye, Hungary
Nagykanizsai Kanizsai Dorottya Korhaz
Nagykanizsa, Zala County, Hungary
Óbudai Egészségügyi Centrum
Budapest, , Hungary
Semmelweis Egyetem
Budapest, , Hungary
Debreceni Egyetem Klinikai Kozpont
Debrecen, , Hungary
Artemis hospital
Gurugram, Haryana, India
Fortis Memorial Research Institute
Gurugram, Haryana, India
Mallikatta Neuro Centre
Mangalore, Karnataka, India
JSS Hospital
Mysore, Karnataka, India
Chopda Medicare & Research Centre Pvt. Ltd; Magnum Heart Institute
Nashik, Maharashtra, India
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India
Sir Ganga Ram Hospital
New Delhi, National Capital Territory of Delhi, India
ASL1 Avezzano-Sulmona-L'Aquila
L’Aquila, Abruzzo, Italy
Ospedale San Paolo Bari
Bari, Apulia, Italy
AOU Policlinico Umberto I
Rome, Lazio, Italy
IRCCS Istituto Neurologico Carlo Besta
Milan, Lombardy, Italy
Asst Spedali Civili Di Brescia
Brescia, , Italy
I.C.O.T. Università La Sapienza
Latina, , Italy
Fondazione Istituto Neurologico C. Mondino
Pavia, , Italy
IRCCS San Raffaele Roma
Roma, , Italy
Konan Medical Center
Kobe, Hyōgo, Japan
Yamaguchi Clinic
Nishinomiya, Hyōgo, Japan
Tominaga Clinic
Osaka, Osaka, Japan
Tokyo Headache Clinic
Shibuya-ku, Tokyo, Japan
Nagaseki Headache Clinic
Kai, Yamanashi, Japan
Tanaka Neurosurgery&Headache Clinic
Kagoshima, , Japan
Tennoji Department of Neurosurgery
Osaka, , Japan
AthleticoMed
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Specjalistyczne Gabinety Sp. z o.o.
Krakow, Lesser Poland Voivodeship, Poland
MIGRE Polskie Centrum Leczenia Migreny
Wroclaw, Lower Silesian Voivodeship, Poland
MedicArt Sp. z o. o.
Wroclaw, Lower Silesian Voivodeship, Poland
NZOZ Neuromed M.i M. Nastaj
Lublin, Lublin Voivodeship, Poland
Centrum Medyczne Hope Clinic Sebastian Szklener
Lublin, Lublin Voivodeship, Poland
Dr Sękowska Leczenie Bólu
Warsaw, Masovian Voivodeship, Poland
Neurosphera
Warsaw, Masovian Voivodeship, Poland
Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś
Warsaw, Masovian Voivodeship, Poland
Detska fakultna nemocnica s poliklinikou Banska Bystrica
Banská Bystrica, , Slovakia
IN MEDIC s.r.o.
Bardejov, , Slovakia
Narodny ustav detskych chorob
Bratislava, , Slovakia
Detsky neurolog s.r.o.
Bratislava, , Slovakia
KONZILIUM s.r.o.
Dubnica nad Váhom, , Slovakia
Univerzitna nemocnica Martin
Martin, , Slovakia
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona [barcelona], Spain
Hospital Universitario HM Puerta del Sur
Madrid, Madrid, Comunidad de, Spain
Clinica Universidad de Navarra
Pamplona, Navarre, Spain
CHUVI- Hospital Alvaro Cunqueiro
Vigo, Pontevedra, Spain
Hospital Universitario HM Sanchinarro
Madrid, , Spain
Hospital Universitario Virgen Del Rocio
Seville, , Spain
Hospital Universitari i Politecnic La Fe
Valencia, , Spain
Hospital Clínico Universitario de Valladolid
Valladolid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BHV3000-320
Identifier Type: OTHER
Identifier Source: secondary_id
2023-505601-16-00
Identifier Type: REGISTRY
Identifier Source: secondary_id
C4951013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.